Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Choudhery, Sadiaa | Lynch, Beverlyb | Sahoo, Sunatib | Seiler, Stephen J.a; *
Affiliations: [a] Department of Radiology, UT Southwestern Medical Center, Dallas, TX, USA | [b] Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA
Correspondence: [*] Corresponding authors: Stephen Seiler, UT Southwestern Medical Center, Department of Radiology, 5323 Harry Hines Blvd. Dallas, TX 75390, USA. Tel.: +1 214 648 4729; Fax: +1 214 648 2678; E-mail: [email protected]
Abstract: Background:With increased utilization of magnetic resonance imaging (MRI) of the breast in clinical practice, many non-mass lesions are being detected incidentally. Although MRI-guided biopsies are usually performed for these lesions, no clear guidelines exist to determine the management of these lesions. Objective:The purpose of this study was to explore the pathological features of incidentally detected non-mass lesions on breast MRI to determine rates of malignancy and to assess the predictive value of kinetic enhancement curves for further characterization of these lesions as benign versus malignant. Methods:A retrospective review was performed of all MRI-guided core needle biopsies done at our institution between January 2009 and January 2012. Results:172 consecutively biopsied lesions were identified. 43% of the lesions were non-mass lesions, out of which 74.3% were benign, whereas 14.9% and 10.8% of these lesions had malignant and atypical features, respectively. The most commonly encountered non-mass malignant lesion was ductal carcinoma in situ, whereas the most frequently seen invasive non-mass lesion was invasive lobular carcinoma. Kinetic enhancement curves for these lesions did not demonstrate a statistically significant relationship with their pathologic features. Conclusions:Non-mass enhancing lesions incidentally detected on breast MRI carry a significant risk of atypia and malignancy, either in situ or invasive. Hence, it is prudent to biopsy these lesions.
Keywords: MRI, breast, non-mass lesions, malignancy, benign breast lesions
DOI: 10.3233/BD-140378
Journal: Breast Disease, vol. 35, no. 1, pp. 13-17, 2015
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]